{
  "id": 18001,
  "title": "HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts",
  "url": "https://urgent.news/2026/07/31/hiv-prevention-drug-could-reduce-cases-globally-but-usaid-cuts",
  "topic": "ai",
  "section": "AI",
  "published": "2026-07-31T16:29:14.000Z",
  "source": {
    "name": "The Guardian",
    "slug": "the-guardian",
    "url": "https://www.theguardian.com/society/2026/jul/31/hiv-aids-medication-usaid-cuts"
  },
  "original_language": "en",
  "account": "Injectable PrEP drug, lenacapavir, holds promise for reducing global HIV cases, but US foreign aid cuts limit access for those most in need, warn experts at the Aids 2026 Conference in Brazil.\n\nOne year after the World Health Organization's recommendation for expanded access to lenacapavir, a major innovation in HIV prevention, investment in HIV prevention has plummeted worldwide, according to experts. This decline in funding creates a significant barrier to access for individuals who require this life-saving medication, particularly in low-resource settings.\n\nLenacapavir, administered via annual injections, boasts a 99% efficacy rate in preventing sexually transmitted HIV when used consistently. It joins other PrEP formulations, such as daily oral medications and bimonthly injections, in offering highly effective protection against HIV transmission.\n\nHowever, without sustained investment from US foreign aid, which was once a crucial supporter of global HIV prevention efforts, those in need may be left without access to this groundbreaking medication. This disparity highlights the urgent need for increased funding and support for HIV prevention initiatives worldwide.",
  "summary": "Injectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide Sign up for the Breaking News US newsletter email New innovations in HIV prevention could dramatically reduce the number of new HIV cases around the globe, but US foreign aid cuts will mean that those that most need the new medication will be unable to access it, according to experts at the…",
  "key_points": [
    "Lenacapavir, an injectable PrEP drug, shows 99% efficacy in preventing HIV transmission.",
    "USAID cuts in foreign aid limit access to lenacapavir for those most in need.",
    "Experts at Aids 2026 Conference warn of funding decline and need for increased support."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Guardian Health",
        "title": "HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts",
        "url": "https://urgent.news/2026/07/31/hiv-prevention-drug-could-reduce-cases-globally-but-usaid-cuts-25992",
        "published": "2026-07-31T16:29:14.000Z"
      },
      {
        "outlet": "Euronews",
        "title": "HIV funding cuts risk 'unravelling decades of progress', global health experts warn",
        "url": "https://urgent.news/2026/08/03/hiv-funding-cuts-risk-unravelling-decades-of-progress-global-health",
        "published": "2026-08-03T05:00:44.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}